EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand

Auttawit Sirichoat iD, Orawee Kaewprasert, Yothin Hinwan, Kiatichai Faksri iD

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0294677 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Auttawit Sirichoat und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand. Hauptthemen laut MEDLINE: Mycobacterium avium Complex, Mycobacterium avium-intracellulare Infection. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Fund of Khon Kaen University which has received funding support from the National Science, Research and Innovation Fund, Young Researcher Development Project of Khon Kaen University Year 2023, Khon Kaen University, Thailand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycobacterium avium complex (MAC) infections are a significant clinical challenge. Determining drug-susceptibility profiles and the genetic basis of drug resistance is crucial for guiding effective treatment strategies. This study aimed to determine the drug-susceptibility profiles of MAC clinical isolates and to investigate the genetic basis conferring drug resistance using whole-genome sequencing (WGS) analysis. Drug-susceptibility profiles based on minimum inhibitory concentration (MIC) assays were determined for 38 MAC clinical isolates (12 Mycobacterium avium and 26 Mycobacterium intracellulare ). Mutations associated with drug resistance were identified through genome analysis of these isolates, and their phylogenetic relationships were also examined. Drug resistance, based on MIC values, was most commonly observed for moxifloxacin (81.6%), followed by linezolid (78.9%), clarithromycin (44.7%) and amikacin (36.8%). We identified specific mutations associated with resistance to amikacin. These include the rrs mutation at C464T in amikacin intermediate-resistance M . avium , and two mutations at T250A and G1453T in amikacin non-susceptible M . intracellulare . Mutations in rrl at A2058G, A2059C and A2059G were potentially linked to clarithromycin resistance. MAC clinical isolates not susceptible to linezolid exhibited mutations in rplC at G237C and C459T, as well as two rplD mutations at G443A and A489G. GyrB substitution Thr521Ala (T521A) was identified in moxifloxacin non-susceptible isolates, which may contribute to this resistance. A phylogeny of our MAC isolates revealed high levels of genetic diversity. Our findings suggest that the standard treatment regimen for MAC infections using moxifloxacin, linezolid, clarithromycin and amikacin may be driving development of resistance, potentially due to specific mutations. The combination of phenotypic and genotypic susceptibility testing can be valuable in guiding the clinical use of drugs for the treatment of MAC infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium avium ComplexMycobacterium avium-intracellulare InfectionHumansClarithromycinAmikacinMoxifloxacinLinezolidThailandPhylogenyDrug Resistance, BacterialMicrobial Sensitivity TestsAnti-Bacterial Agents

Substanzen

ClarithromycinAmikacinMoxifloxacinLinezolidAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Research and Diagnostic Center for Emerging Infectious Diseases (RCEID), Khon Kaen University, Khon Kaen, Thailand.

ORCID-Profile: Auttawit Sirichoat, Kiatichai Faksri

Förderung

  • Fundamental Fund of Khon Kaen University which has received funding support from the National Science, Research and Innovation Fund
  • Young Researcher Development Project of Khon Kaen University Year 2023, Khon Kaen University, Thailand

Zitieren

APA

Sirichoat, A., Kaewprasert, O., Hinwan, Y., & Faksri, K. (2023). Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand. PLOS ONE. https://doi.org/10.1371/journal.pone.0294677

Vancouver

Sirichoat A, Kaewprasert O, Hinwan Y, Faksri K. Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand. PLOS ONE. 2023. doi:10.1371/journal.pone.0294677

BibTeX
@article{Sirichoat2023,
  author = {Sirichoat, Auttawit and Kaewprasert, Orawee and Hinwan, Yothin and Faksri, Kiatichai},
  title = {Phenotypic drug-susceptibility profiles and genetic analysis based on whole-genome sequencing of Mycobacterium avium complex isolates in Thailand},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0294677}
}
Kostenlos starten →